| Knife River Care Center | |
| 118 22nd St Ne, Beulah, North Dakota 58523 | |
| (701) 873-4322 | |
| Name | Knife River Care Center |
|---|---|
| Location | 118 22nd St Ne, Beulah, North Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 86 |
| Occupancy Rate | 93.49% |
| Medicare ID (CCN) | 355053 |
| Legal Business Name | Beulah Community Nursing Home |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1740283860 |
| Organization Name | BEULAH COMMUNITY NURSING HOME |
| Doing Business As | KNIFE RIVER CARE CENTER |
| Address | 118 22nd St Ne, Beulah, ND 58523 |
| Phone Number | 701-873-4322 |
News Archive
Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.
Cannabis - marijuana, hashish - was used as a go-to medical remedy by societies around the world for centuries. But the therapeutic use of marijuana was banned in most countries in the 1930s and '40s due to a growing awareness of the dangers of addiction. The significant medical benefits of marijuana in alleviating symptoms of such diseases as Parkinson's, cancer, and multiple sclerosis have only recently been reinvestigated.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Scientists from the University of Gothenburg, Sweden, have found a new method of reducing human body weight and fat mass using weighted vests.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.
Cannabis - marijuana, hashish - was used as a go-to medical remedy by societies around the world for centuries. But the therapeutic use of marijuana was banned in most countries in the 1930s and '40s due to a growing awareness of the dangers of addiction. The significant medical benefits of marijuana in alleviating symptoms of such diseases as Parkinson's, cancer, and multiple sclerosis have only recently been reinvestigated.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Scientists from the University of Gothenburg, Sweden, have found a new method of reducing human body weight and fat mass using weighted vests.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $46559 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.07 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.75 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 35.77 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.38 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.31 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.37 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.06 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.37 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.33 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.47 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.48 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.52 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.11 | 82.93 |
News Archive
Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.
Cannabis - marijuana, hashish - was used as a go-to medical remedy by societies around the world for centuries. But the therapeutic use of marijuana was banned in most countries in the 1930s and '40s due to a growing awareness of the dangers of addiction. The significant medical benefits of marijuana in alleviating symptoms of such diseases as Parkinson's, cancer, and multiple sclerosis have only recently been reinvestigated.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Scientists from the University of Gothenburg, Sweden, have found a new method of reducing human body weight and fat mass using weighted vests.
› Verified 2 days ago